Analysis of formulation effects in the dissolution of ibuprofen pellets

International Journal of Pharmaceutics

Volumn 270, Issue 1-2, 2004, Pages 9-19

  Costa, F O ^a   Pais, A A C C ^b   Sousa, J J S ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Density; Drug release; Pellets; Porosity; Porosity parameters; Specific area

Indexed keywords

CALCIUM PHOSPHATE; CITRIC ACID; GRANULAR; IBUPROFEN; LACTOSE;

ARTICLE; BULK DENSITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; PARTICLE SIZE; PH; POROSITY; PRIORITY JOURNAL; TABLET;

EID: 0346392136     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.10.002     Document Type: Article

References (30)

1. AHFH Drug Information, 2002. American Society of Health-System Pharmacists, Maryland.
2. Alvarez L., Concheiro A., Gómez-Amoza J.L., Souto C., Martínez-Pacheco R., Effect of microcrystlline cellulose grade and process variables on pellets prepared by extrusion-spheronization. Drug Dev. Ind. Pharm. 28:2002;451-456.
3. Berggren J., Alderborn G., Effect of drying rate on porosity and tabletting behaviour of cellulose pellets. Int. J. Pharm. 227:2001;81-96.
4. Byrne R.S., Deasy P.B., Use of commercial porous ceramic for sustained drug delivery. Int. J. Pharm. 246:2002;61-73.
5. Chopra R., Newton J.M., Alderborn G., Podczeck F., Preparation of pellets of different shape and their characterization. Pharm. Dev. Tech. 6:2001;495-503.
6. Conine J.W., Hadley H.R., Preparation of small solid spheres. Drug Cosmet. Ind. 106:1970;38-41.
7. Costa F.O., Sousa J.J.S., Pais A.A.C.C., Formosinho J.S., Comparison of dissolution profiles of ibuprofen pellets. J. Control Rel. 89:2003;199-212.
8. Dees P.J., Polderman J., Mercury porosimetry in pharmaceutical technology. Powder Tech. 29:1981;187-197.
9. Fujiwara H., Toda J., Kato M., Studies on pore structure of granules by mercury porosimetry. Chem. Pharm. Bull. 14:1966;601-607.
10. Goskonda S.R., Hileman G.A., Upadrashta S.M., Controlled release pellets by extrusion-spheronization. Int. J. Pharm. 111:1994;89-97.
11. Healy A.M., Corrigan O.I., The influence of excipient particle size, solubility and acid strength on the dissolution of an acidic drug from two-component compacts. Int. J. Pharm. 143:1996;211-221.
12. Handbook of Pharmaceutical Excipients, 2000. American Pharmaceutical Association, Washington DC and Pharmaceutical Press, London.
13. Johansson B., Alderborn G., The effect of shape and porosity on the compreession behaviour and tablet forming ability of granular materials formed from microcrystalline cellulose. Eur. J. Pharm. Biopharm. 52:2001;347-357.
14. Khan G.M., Zhu J.B., Ibuprofen release kinetics from controlled-release tablets granulated with aqueus polymeric dispersion of ethylcellulose. II: Influence of several parameters and coexcipients. J. Control Rel. 56:1998;127-134.
15. Krogars K., Heinämäki J., Vesalahti J., Marvola M., Antikainen O., Yliruusi J., Extrusion-spheronization of pH-sensitive polymeric matrix pellets for possible colonic drug delivery. Int. J. Pharm. 199:2000;187-194.
16. Lowell, S., Shields, J.E., 1991. Powder Surface Area and Porosity, 3rd ed. Chapman & Hall, New York.
17. Mehta K.A., Kislalioglu M.S., Phuapradit W., Malick A.W., Shah N.H., Effect of formulation on process variables and porosity parameters and release rates from a multi unit erosion matrix of a poorly soluble drug. J. Control Rel. 63:2000;201-211.
18. Nykänen P., Krogars K., Säkkinen M., Heinämäki J., Jürjensson H., Veski P., Marvola M., Organic acids as excipients in matrix granules for colon-specific drug delivery. Int. J. Pharm. 184:1999;251-261.
19. Orr C. Jr., Application of mercury penetration to materials analysis. Powder Tech. 3:1970;117-123.
20. Pinto J.F., Lameiro M.H., Martins P., Investigation on the co-extrudability and spheronization properties of wet masses. Int. J. Pharm. 227:2001;71-80.
21. Reynolds A.D., PA new technique for the production of spherical particles. Manufact. Chem. Aerosol. News. 41:1970;40-43.
22. Rodriguez E.C., Torrado J.J., Nikolakakis I., Torrado S., Lastres J.L., Malamataris S., Micromeritic and packing properties of diclofenac pellets and effects of some formulation variables. Drug Dev. Ind. Pharm. 27:2001;847-855.
23. Santos H., Veiga F., Pina M., Podczeck F., Sousa J., Physical properties of chitosan pellets produced by extrusion-spheronization: influence of formulation variables. Int. J. Pharm. 246:2002;153-169.
24. Shively M.L., Analysis of mercury porosimetry for the evaluation of pore shape and intrusion-extrusion hysteresis. J. Pharm. Sci. 80:1991;376-379.
25. Sousa J., Sousa A., Moura M., Podczeck F., Newton J., The influence of core materials and film coating on the drug release from coated pellets. Int. J. Pharm. 233:2002a;111-122.
26. Sousa J., Sousa A., Podczeck F., Newton J., Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int. J. Pharm. 232:2002b;91-106.
27. Sousa J.J., Sousa A., Podczeck F., Newton J.M., Influence of process conditions on drug release from pellets. Int. J. Pharm. 144:1996;159-169.
28. Tho I., Sande S.A., Kleinebudde P., Pectinic acid, a novel excipient for production of pellets by extrusion/spheronization: preliminary studies. Eur. J. Pharm. Biopharm. 54:2002;95-99.
29. Tomer G., Podczeck F., Newton J.M., The influence of type and quantity of model drug on the extrusion/spheronization of mixtures with microcrystalline cellulose. I. Extrusion parameters. Int. J. Pharm. 217:2001;237-248.
30. Vergote G.J., Vervaet C., Driessche I.V., Hoste S., Smedt S.D., Demeester J., Jain R.A., Ruddy S., Remon J.P., An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int. J. Pharm. 219:2001;81-87.